MOR Wealth Management LLC purchased a new stake in shares of Planet Labs PBC (NYSE:PL – Free Report) during the 4th quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The fund purchased 16,898 shares of the company’s stock, valued at approximately $333,000.
A number of other institutional investors also recently bought and sold shares of the stock. Spire Wealth Management lifted its holdings in Planet Labs PBC by 526.7% in the fourth quarter. Spire Wealth Management now owns 4,700 shares of the company’s stock worth $93,000 after buying an additional 3,950 shares during the period. Connective Portfolio Management LLC purchased a new position in shares of Planet Labs PBC during the 4th quarter worth approximately $1,578,000. 180 Wealth Advisors LLC raised its position in shares of Planet Labs PBC by 0.9% in the 4th quarter. 180 Wealth Advisors LLC now owns 148,309 shares of the company’s stock worth $2,925,000 after acquiring an additional 1,277 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its position in shares of Planet Labs PBC by 6.0% in the 4th quarter. Wealth Enhancement Advisory Services LLC now owns 33,126 shares of the company’s stock worth $723,000 after acquiring an additional 1,862 shares in the last quarter. Finally, GAMMA Investing LLC lifted its stake in shares of Planet Labs PBC by 146.4% in the 4th quarter. GAMMA Investing LLC now owns 2,011 shares of the company’s stock valued at $40,000 after purchasing an additional 1,195 shares during the period. 41.71% of the stock is owned by institutional investors.
Analyst Upgrades and Downgrades
PL has been the topic of several research reports. National Bank Financial set a $12.30 price target on Planet Labs PBC in a research report on Tuesday, December 16th. Needham & Company LLC raised their price objective on Planet Labs PBC to $40.00 and gave the company a “buy” rating in a research report on Friday, March 20th. Northland Securities set a $28.00 target price on shares of Planet Labs PBC in a report on Tuesday, January 13th. Cantor Fitzgerald upped their target price on shares of Planet Labs PBC from $20.00 to $40.00 and gave the stock an “overweight” rating in a research report on Friday, March 20th. Finally, The Goldman Sachs Group reiterated a “neutral” rating and issued a $16.40 price target on shares of Planet Labs PBC in a research note on Tuesday, January 20th. Six equities research analysts have rated the stock with a Buy rating, four have issued a Hold rating and one has assigned a Sell rating to the company. Based on data from MarketBeat, the company presently has an average rating of “Hold” and a consensus target price of $27.25.
Planet Labs PBC Trading Up 0.2%
Planet Labs PBC stock opened at $30.93 on Monday. Planet Labs PBC has a 12 month low of $2.79 and a 12 month high of $37.05. The company has a market capitalization of $10.71 billion, a price-to-earnings ratio of -39.66 and a beta of 1.95. The business’s fifty day simple moving average is $25.76 and its two-hundred day simple moving average is $18.87. The company has a current ratio of 1.65, a quick ratio of 1.64 and a debt-to-equity ratio of 2.37.
Planet Labs PBC (NYSE:PL – Get Free Report) last posted its quarterly earnings results on Thursday, March 19th. The company reported ($0.48) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.05) by ($0.43). The company had revenue of $86.82 million during the quarter, compared to analysts’ expectations of $78.17 million. Planet Labs PBC had a negative return on equity of 69.61% and a negative net margin of 80.22%.The firm’s revenue was up 41.1% on a year-over-year basis. As a group, equities analysts predict that Planet Labs PBC will post -0.37 earnings per share for the current fiscal year.
Insider Buying and Selling at Planet Labs PBC
In related news, Director Vijaya Gadde sold 20,000 shares of the company’s stock in a transaction that occurred on Thursday, January 22nd. The stock was sold at an average price of $26.77, for a total value of $535,400.00. Following the transaction, the director directly owned 250,169 shares of the company’s stock, valued at approximately $6,697,024.13. This represents a 7.40% decrease in their position. The transaction was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, Director Kristen Robinson sold 47,835 shares of the stock in a transaction on Wednesday, January 21st. The shares were sold at an average price of $26.96, for a total value of $1,289,631.60. Following the sale, the director owned 222,897 shares in the company, valued at approximately $6,009,303.12. This represents a 17.67% decrease in their ownership of the stock. Additional details regarding this sale are available in the official SEC disclosure. In the last ninety days, insiders sold 218,566 shares of company stock worth $5,896,276. 17.53% of the stock is owned by corporate insiders.
Planet Labs PBC News Roundup
Here are the key news stories impacting Planet Labs PBC this week:
- Positive Sentiment: Planet expanded production capacity in Berlin to serve growing European AI satellite demand — a clear revenue-growth and TAM-expansion signal that investors rewarded with recent price gains. Planet Labs Expands Berlin Production To Serve European AI Satellite Demand
- Positive Sentiment: Analyst upgrades and bullish notes (including a Morgan Stanley call) have lifted sentiment and helped push the stock to new highs; coverage momentum can attract more institutional interest. Morgan Stanley Analyst Says Stock Price Expected to Rise
- Positive Sentiment: Media pieces highlight a very strong 12‑month performance and the company delivering its first full fiscal year of profitability, reinforcing a longer-term growth + earnings narrative. Planet Labs Stock Has Risen 765% in a Year
- Neutral Sentiment: Brokerage consensus sits around “Hold,” suggesting some analysts see upside but others prefer to wait for more proof of sustainable margins and execution. Given Average Recommendation of “Hold” by Brokerages
- Neutral Sentiment: Market commentary highlights the stock’s recent strong performance and notes broader macro headlines driving short-term market volatility — useful context but not company-specific. MarketBeat Week in Review – 03/23 – 03/27
- Negative Sentiment: Planet announced redemption of all outstanding public warrants. That move removes an overhang long term but can trigger near-term selling pressure as warrant holders decide to exercise, sell or accept redemption; it also brings cap‑table and cash/financing implications that investors must parse from the redemption terms. This announcement appears to be the immediate catalyst for the intraday pullback. Planet Labs Announces Redemption of Outstanding Public Warrants Planet Announces Redemption of Public Warrants
Planet Labs PBC Company Profile
Planet Labs PBC is a public benefit corporation that operates one of the largest fleets of Earth-imaging satellites, providing high-frequency, high-resolution imagery and data analytics to a broad range of industries. The company’s multi-spectral satellite constellation captures daily snapshots of the planet, enabling clients to monitor changes in agriculture, forestry, urban development, energy infrastructure and environmental conditions. Planet’s imagery platform is designed to support timely decision-making by transforming raw satellite data into actionable insights for business and government users.
Founded in 2010 by former NASA scientists Will Marshall, Robbie Schingler and Chris Boshuizen, Planet Labs grew from a small startup into a key provider in the satellite imaging sector.
See Also
Receive News & Ratings for Planet Labs PBC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Planet Labs PBC and related companies with MarketBeat.com's FREE daily email newsletter.
